Postoperative Sore Throat

Uses

Risks & contraindications

Comparisons

Evidence quality

Highlighted claims

• The trial is powered to detect an absolute reduction of 15 percentage points in POST incidence with the VBB approach. — Laryngeal mask airway combined with visual bronchial blocker versus double-lumen tube for lung isolation in video-assisted thoracoscopic surgery: a protocol for a multicentre randomised controlled trial
• The primary endpoint is the composite incidence of sore throat and/or hoarseness at 24 hours postoperatively. — Laryngeal mask airway combined with visual bronchial blocker versus double-lumen tube for lung isolation in video-assisted thoracoscopic surgery: a protocol for a multicentre randomised controlled trial
• Postoperative sore throat and hoarseness outcomes conflict with enhanced recovery after surgery goals in thoracic surgery. — Laryngeal mask airway combined with visual bronchial blocker versus double-lumen tube for lung isolation in video-assisted thoracoscopic surgery: a protocol for a multicentre randomised controlled trial
• DLT-associated sore throat, hoarseness, and oedema can delay oral intake, increase analgesic requirements, prolong recovery, and extend hospital stays. — Laryngeal mask airway combined with visual bronchial blocker versus double-lumen tube for lung isolation in video-assisted thoracoscopic surgery: a protocol for a multicentre randomised controlled trial
• Published POST rates with DLT are 35–45%, and the trial control group event rate is assumed to be 30%. — Laryngeal mask airway combined with visual bronchial blocker versus double-lumen tube for lung isolation in video-assisted thoracoscopic surgery: a protocol for a multicentre randomised controlled trial